An Asia-based drug product manufacturer needed Freyr's services to prepare and submit a response to deficiency letter received from the Saudi FDA and other related Regulatory actions required to gain market access. As the scope of the work available for the source documents from the client on time for MAA response compilation, the project was challenging to execute due to difficulty in managing operational activities to prepare a response to SFDA's Deficiency Letter and fulfilling submission deadlines.

Download the proven case to learn how Freyr delivered specialized Regulatory functionalities to help the client ensure that MAA response submission activity was completed on time.